Rapid recommendations: Updates from 2022 guidelines: part 1
- PMID: 37172987
- PMCID: PMC10177652
- DOI: 10.46747/cfp.6905338
Rapid recommendations: Updates from 2022 guidelines: part 1
References
-
- Khoury M, Bigras JL, Cummings EA, Harris KC, Hegele RA, Henderson M, et al. The detection, evaluation, and management of dyslipidemia in children and adolescents: a Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association clinical practice update. Can J Cardiol 2022;38(8):1168-79. - PubMed
-
- Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;139(25):e1082-143. Epub 2018 Nov 10. Erratum in: Circulation 2019;139(25):e1182-6. Epub 2019 Jun 17. - PMC - PubMed
-
- Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145(18):e876-94. Epub 2022 Apr 1. Errata in: Circulation 2022;145(18):e1033, Circulation 2022;146(13):e185, Circulation 2023;147(14):e674.
-
- Mancini GBJ, O’Meara E, Zieroth S, Bernier M, Cheng AYY, Cherney DZI, et al. 2022 Canadian Cardiovascular Society guideline for use of GLP-1 receptor agonists and SGLT2 inhibitors for cardiorenal risk reduction in adults. Can J Cardiol 2022;38(8):1153-67. Erratum in: Can J Cardiol 2022;38(12):1979. - PubMed
-
- American Diabetes Association Professional Practice Committee . 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2022. Diabetes Care 2022;45(Suppl 1):S125-43. - PubMed
LinkOut - more resources
Full Text Sources